Mendelian — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Mendelian is a London-based diagnostics company tackling the significant challenge of delayed rare disease diagnosis. The company's AI-powered software platform, MendelScan, integrates with primary care health record systems to systematically scan for patients whose symptoms match encoded clinical criteria for rare conditions, aiming to reduce misdiagnoses, unnecessary referrals, and healthcare costs. Backed by NHS awards and partnerships, Mendelian operates a B2B business model, selling its software as a medical device to healthcare providers like the NHS to improve care pathways and enable timely specialist referral and genomic testing.

Rare Diseases

Technology Platform

MendelScan: An expert-guided, AI-powered software platform that integrates with electronic health records to scan patient populations for clinical features matching encoded criteria for rare and hard-to-diagnose diseases, generating actionable reports for primary care clinicians.

Opportunities

Significant market opportunity driven by high cost of undiagnosed rare diseases to public health systems and aligned policy initiatives like Genome UK.

Potential to expand beyond the UK to other European countries with national rare disease plans and to broaden the platform's scope to other complex, hard-to-diagnose conditions.

Risk Factors

Risks include slow adoption within large healthcare systems, the challenge of continuous clinical validation of AI algorithms, and regulatory hurdles as a medical device software.

Competition from larger EHR vendors and other AI diagnostics startups also presents a market risk.

Competitive Landscape

Mendelian operates in the competitive AI-driven clinical decision support and rare disease diagnostics space. Competitors include other digital health startups focusing on rare disease phenotyping and diagnosis, as well as large electronic health record vendors that may integrate similar AI tools. Mendelian's differentiator is its specific focus on primary care workflow integration and its clinician-led, criteria-encoding approach.

More companies in Diagnostics & Precision Medicine →More companies in United Kingdom →